Subclinical rejection in tacrolimus-treated renal transplant recipients

James M. Gloor, Ari J. Cohen, Donna J. Lager, Joseph P. Grande, Mary E. Fidler, Jorge A. Velosa, Timothy S. Larson, Thomas R. Schwab, Matthew D. Griffin, Mikel Prieto, Scott L. Nyberg, Sylvester Sterioff, Walter K. Kremers, Mark D. Stegall

Research output: Contribution to journalArticle

87 Scopus citations

Abstract

Background. Subclinical rejection, defined as histologic acute rejection in the absence of graft dysfunction, has been suggested as a cause of chronic allograft rejection. In cyclosporine-treated patients, the incidence of subclinical rejection 3 months after transplant is reported to be approximately 30%. The intent of our study was to determine the incidence of subclinical rejection in tacrolimus-treated renal allograft recipients. Methods. We prospectively studied the incidence of subclinical rejection on surveillance biopsies performed 3 months after transplantation in 114 patients transplanted between September 1, 1998 and November 30, 2000. All patients received tacrolimus, mycophenolate mofetil, and prednisone, and 56% received antibody induction. Results. Subclinical rejection was detected in 2.6% of patients (3/114, 95% confidence interval 0.5-7.5%). Borderline changes were detected in 11% (12/114). Subclinical rejections were treated with bolus methylprednisolone. Conclusions. The incidence of subclinical rejection early after kidney transplantation is extremely low in tacrolimus-treated patients in whom early rejections are aggressively treated, suggesting that surveillance biopsies may not be necessary with this regimen.

Original languageEnglish (US)
Pages (from-to)1965-1968
Number of pages4
JournalTransplantation
Volume73
Issue number12
DOIs
StatePublished - Jun 27 2002

ASJC Scopus subject areas

  • Transplantation

Fingerprint Dive into the research topics of 'Subclinical rejection in tacrolimus-treated renal transplant recipients'. Together they form a unique fingerprint.

  • Cite this

    Gloor, J. M., Cohen, A. J., Lager, D. J., Grande, J. P., Fidler, M. E., Velosa, J. A., Larson, T. S., Schwab, T. R., Griffin, M. D., Prieto, M., Nyberg, S. L., Sterioff, S., Kremers, W. K., & Stegall, M. D. (2002). Subclinical rejection in tacrolimus-treated renal transplant recipients. Transplantation, 73(12), 1965-1968. https://doi.org/10.1097/00007890-200206270-00023